Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001200302 | SCV001371223 | uncertain significance | not provided | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV001200302 | SCV001447384 | likely pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
3billion | RCV001809992 | SCV002058969 | uncertain significance | Developmental and epileptic encephalopathy, 64 | 2022-01-03 | criteria provided, single submitter | clinical testing | Same nucleotide change resulting in same amino acid change has been previously reported to be associated with RHOBTB2 related disorder (ClinVar ID: VCV000932476, PS1_P). In silico tool predictions suggest damaging effect of the variant on gene or gene product (3CNET: 0.983, PP3_P). A missense variant is a common mechanism associated with Epileptic encephalopathy (PP2_P). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. |